Shanghai Hutchison Pharmaceuticals was selected as "Top 100 Chinese Patent Medicine Companies" and Shexiang Baoxin Pills were listed on "2021 Clinical Value Chinese Patent Medicine Brand List"

<>/* Style Definitions */ span.

In recent years, with the great attention and policy support of the Party Central Committee and the State Council, the development momentum of the Chinese medicine industry has been strong
.

In order to shape the brand image, enhance the overall competitiveness of Chinese medicine companies, and promote the high-quality development of the Chinese medicine industry, the China Association of Chinese Medicines has launched the selection of clinical value Chinese patent medicine brands and TOP100 Chinese patent medicine companies

Shanghai Hutchison Pharmaceuticals has 74 products, including pills, tablets, injections and other dosage forms, the registered trademark of "Shangyao", and a series of modern Chinese medicine products such as Shexiang Baoxin Pills, Danning Tablets, and Shengmai Injection
.

On the basis of inheriting classic traditional Chinese medicine products, relying on Hutchison Whampoa’s strong technical research and development capabilities, the company has invested a lot of money, continuously applied international advanced science and technology and methods to carry out secondary development of traditional Chinese medicine products, and further clarified the medicine of compound Chinese medicine.

Shexiang Baoxin Pills originated from the famous prescription Suhexiang Pills in the Song Dynasty.

It was marketed in 1981.

In 2020, the results of a large-scale evidence-based study of Shexiang Baoxin Pills, led by academician of the Chinese Academy of Sciences, Professor Ge Junbo of Zhongshan Hospital Affiliated to Fudan University, and Professor Fan Weihu of Huashan Hospital Affiliated to Fudan University, in line with international standards, were published in the Chinese Medical Journal.

Edition", CMJ for short) was officially published

Danning tablets, another key product of the company, obtained the Canadian natural medicine marketing license and the certification of production sites outside Canada in 2016 and 2019 respectively, becoming one of the successful models of the internationalization of traditional Chinese medicine
.

Shanghai Hutchison Pharmaceuticals adheres to the mission of "innovating traditional Chinese medicines and serving healthy China", and continuously promotes the modernization and internationalization of Chinese medicines
.

In 2017, the company's academician expert workstation was awarded the "National Demonstration Academician Expert Workstation"; in 2019, the company's enterprise technology center was awarded the "National Enterprise Technology Center"; in 2021, the company was awarded the "National Technological Innovation Demonstration Enterprise"